Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Characterization of P1 promoter activity of the beta-galactoside alpha2,6-sialyltransferase I gene (siat 1) in cervical and hepatic cancer cell lines.

Milflores-Flores L, Millán-Pérez L, Santos-López G, Reyes-Leyva J, Vallejo-Ruiz V.

J Biosci. 2012 Jun;37(2):259-67.

3.

Ras oncogene induces beta-galactoside alpha2,6-sialyltransferase (ST6Gal I) via a RalGEF-mediated signal to its housekeeping promoter.

Dalziel M, Dall'Olio F, Mungul A, Piller V, Piller F.

Eur J Biochem. 2004 Sep;271(18):3623-34.

5.

Mouse ST6Gal sialyltransferase gene expression during mammary gland lactation.

Dalziel M, Huang RY, Dall'Olio F, Morris JR, Taylor-Papadimitriou J, Lau JT.

Glycobiology. 2001 May;11(5):407-12.

PMID:
11425801
6.

Transcriptional regulation of human beta-galactoside alpha2,6-sialyltransferase (hST6Gal I) gene in colon adenocarcinoma cell line.

Xu L, Kurusu Y, Takizawa K, Tanaka J, Matsumoto K, Taniguchi A.

Biochem Biophys Res Commun. 2003 Aug 8;307(4):1070-4.

PMID:
12878221
7.

Enhanced expression of alpha 2,6-sialyltransferase ST6Gal I in cervical squamous cell carcinoma.

Wang PH, Lee WL, Lee YR, Juang CM, Chen YJ, Chao HT, Tsai YC, Yuan CC.

Gynecol Oncol. 2003 Jun;89(3):395-401. Erratum in: Gynecol Oncol. 2004 Jun;93(3):722-3.

PMID:
12798701
9.

Developmental regulation of beta-galactoside alpha 2,6-sialyltransferase in small intestine epithelium.

Vertino-Bell A, Ren J, Black JD, Lau JT.

Dev Biol. 1994 Sep;165(1):126-36.

PMID:
8088431
10.

Promoter polymorphisms of ST3GAL4 and ST6GAL1 genes and associations with risk of premalignant and malignant lesions of the cervix.

Rivera-Juarez Mde L, Rosas-Murrieta NH, Mendieta-Carmona V, Hernandez-Pacheco RE, Zamora-Ginez I, Rodea-Avila C, Apresa-Garcia T, Garay-Villar O, Aguilar-Lemarroy A, Jave-Suarez LF, Diaz-Orea MA, Milflores-Flores L, Reyes-Salinas JS, Ceja-Utrera FJ, Vazquez-Zamora VJ, Vargas-Maldonado T, Reyes-Carmona S, Sosa-Jurado F, Santos-Lopez G, Reyes-Leyva J, Vallejo-Ruiz V.

Asian Pac J Cancer Prev. 2014;15(3):1181-6.

11.

Biologic contribution of P1 promoter-mediated expression of ST6Gal I sialyltransferase.

Appenheimer MM, Huang RY, Chandrasekaran EV, Dalziel M, Hu YP, Soloway PD, Wuensch SA, Matta KL, Lau JT.

Glycobiology. 2003 Aug;13(8):591-600. Epub 2003 Apr 2.

PMID:
12672700
12.

n-butyrate reduces the expression of beta-galactoside alpha 2,6-sialyltransferase in Hep G2 cells.

Shah S, Lance P, Smith TJ, Berenson CS, Cohen SA, Horvath PJ, Lau JT, Baumann H.

J Biol Chem. 1992 May 25;267(15):10652-8.

13.
15.

Differential regulation of alternate UDP-glucuronosyltransferase 1A6 gene promoters by hepatic nuclear factor-1.

Auyeung DJ, Kessler FK, Ritter JK.

Toxicol Appl Pharmacol. 2003 Sep 1;191(2):156-66.

PMID:
12946651
16.
17.

Differences in CD75s- and iso-CD75s-ganglioside content and altered mRNA expression of sialyltransferases ST6GAL1 and ST3GAL6 in human hepatocellular carcinomas and nontumoral liver tissues.

Souady J, Hülsewig M, Distler U, Haier J, Denz A, Pilarsky C, Senninger N, Dreisewerd K, Peter-Katalinic J, Müthing J.

Glycobiology. 2011 May;21(5):584-94. doi: 10.1093/glycob/cwq200. Epub 2010 Dec 7.

PMID:
21147760
19.

Transcriptional activity and Sp 1/3 transcription factor binding to the P1 promoter sequences of the human AbetaH-J-J locus.

Feriotto G, Finotti A, Breveglieri G, Treves S, Zorzato F, Gambari R.

FEBS J. 2007 Sep;274(17):4476-90. Epub 2007 Aug 6.

Supplemental Content

Support Center